BAX
Baxter International Inc. · Healthcare · Medical - Instruments & Supplies
Momentum inputs (comparable managers):
holder breadth -5.6% ·
share flow +15.6% ·
net new positions -5.9%
· formula
Concentrated accumulation: rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 136 | -1 | 390.14M | $8.32B | +8 | −10 |
| Q1 2026 | 141 | -12 | 367.10M | $6.16B | +4 | −17 |
| Q4 2025 | 152 | +2 | 422.38M | $8.07B | +4 | −1 |
| Q3 2025 | 21 | 0 | 287.33M | $6.54B | +1 | −2 |
| Q2 2025 | 19 | -1 | 263.48M | $7.98B | n/a | −1 |
| Q1 2025 | 17 | 0 | 122.55M | $4.20B | +1 | −1 |
| Q4 2024 | 17 | -1 | 116.71M | $3.41B | +1 | −2 |
| Q3 2024 | 17 | -1 | 90.14M | $3.42B | n/a | −1 |
| Q2 2024 | 18 | n/a | 78.00M | $2.61B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 44.60M | +62.0% | $1.69B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 14.85M | +0.3% | $563.75M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Geode Capital Management ✦ (passive) | 12.16M | +1.4% | $460.02M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | Harris Associates (Oakmark) ✦ | 9.78M | -5.3% | $371.21M | 0.6% | ▼ Trim | 2 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (passive) | 5.27M | -17.1% | $200.20M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Adage Capital Partners ✦ | 1.56M | +219.8% | $59.37M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 614.64K | -34.1% | $23.07M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 8 | Arrowstreet Capital ✦ | 423.38K | -17.8% | $16.08M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 385.10K | -86.5% | $14.62M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 10 | GAMCO Investors ✦ | 158.67K | +1.1% | $6.02M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | Bridgewater Associates ✦ | 149.32K | -76.0% | $5.67M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Millennium Management ✦ | 81.50K | -92.7% | $3.09M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Gotham Asset Management ✦ | 45.35K | -62.2% | $1.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Wellington Management ✦ | 28.27K | -8.8% | $1.07M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 15 | D. E. Shaw & Co. ✦ | 17.69K | -82.4% | $671,537 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Tweedy, Browne ✦ | 9.86K | 0.0% | $374,422 | 0.0% | Held | 2 | SEC ↗ |
| 17 | Marshall Wace ✦ | 7.34K | -84.6% | $278,851 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Two Sigma Investments | $506,433 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 655 holders, 526.17M shares, $8.60B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.